Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

FDA's plan to diversify clinical trials falls flat, study finds

Five years ago, the Food and Drug Administration began implementing a plan to increase diversity and transparency in its clinical trials of medicines.

So what progress has been made? Well, not nearly enough, according to the reporting of Ed Silverman, a senior writer for STAT.

This article was originally published on WBUR.org.

Copyright 2022 NPR. To see more, visit https://www.npr.org.